Should a standard lymphadenectomy during pancreatoduodenectomy exclude para-aortic lymph nodes for all cases of resectable pancreatic head cancer? A consensus statement by the Chinese Study Group for Pancreatic Cancer (CSPAC)
机构：[1]Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center Department of Oncology,Shanghai Medical College, Fudan University Pancreatic Cancer Institute, Fudan University, Shanghai[2]Department of Pancreaticobiliary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou中山大学附属第二医院[3]Department of Abdominal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College,Beijing[4]Department of Pancreatic Surgery, Pancreatic Disease Institute, Huashan Hospital, Shanghai Medical College,Fudan University, Shanghai[5]Department of Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial People's Hospital,Hangzhou[6]Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin[7]Department of General Surgery of Heilongjiang Provincial Hospital, Harbin, Heilongjiang[8]Department of Surgery,Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou[9]Department of Hepatobiliary Oncology,Cancer Center, Sun Yat-sen University, Guangzhou[10]Department of Pancreatic-Bililary Surgery, Xiangya Hospital,Central South University, Changsha, Hunan[11]Department of Hepatobiliopancreatic Surgery, The People's Hospital of Deyang,Deyang[12]Department of Gastroenterological and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou[13]Department of Hepato-Pancreato-Biliary Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang河北医科大学第四医院[14]Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital and Institute, Beijing[15]Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College,Huazhong University of Science and Technology, Wuhan华中科技大学同济医学院附属同济医院[16]Department of Pancreatic and Biliary Surgery,The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang[17]Department of Pancreatic-Biliary Surgery,Shanghai Changzheng Hospital, Second Military Medical University[18]Department of Biliary-Pancreatic Surgery,Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai[19]Department of Hepato-Biliary-Pancreatic Surgery,West China Hospital, Sichuan University, Chengdu四川大学华西医院[20]Department of Surgery, Huadong Hospital, Fudan University, Shanghai[21]Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine,Hangzhou浙江大学医学院附属第一医院[22]The Pancreatic Disease Institute, Union Hospital, Tongji Medical College,Huazhong University of Science and Technology, Wuhan, P.R. China华中科技大学同济医学院附属协和医院
Understanding and formulating an appropriate strategy for the para-aortic lymph nodes (LN16) during curative surgery for pancreatic head cancer have been controversial for some time. This study intended to provide a recommendation for surgeons to perform an optimal curative surgery on pancreatic cancer patients with or without LN16 involvement. Based on an updated literature search and review, the members of the Chinese Study Group for Pancreatic Cancer (CSPAC) from high-volume centers reached a consensus on the issue of LN16 in pancreatic head cancer. Metastasis to LN16 is quite common in pancreatic head cancer cases. Depending on the location of the tumor, including the ventral and dorsal pancreas, there could be various lymph node drainage pathways whereby LN16 does not necessarily belong to the Group 3 lymph node stations for all cases of pancreatic head cancer. Although LN16 involvement generally indicates a poor prognosis, some cohorts of LN16-involved cases have benefited from a curative surgery, and there is still a lack of level I evidence to convince surgeons to abandon all resectable cases with LN16 positivity. Resection of LN16 combined with a standard lymphadenectomy during pancreatoduodenectomy is recommended by CSPAC, except in patients with both positive LN16 and criteria based on: i) the resectability status of primary tumor; ii) the extent of involved para-aortic lymph nodes; and iii) the serum tumor burden assessed preoperatively.
第一作者机构：[1]Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center Department of Oncology,Shanghai Medical College, Fudan University Pancreatic Cancer Institute, Fudan University, Shanghai
通讯机构：[*1]Department of Pancreatic and Hepatobiliary Surgery, Shanghai Cancer Center, Pancreatic Cancer Institute, Fudan University, 270 Dong An Road, Shanghai 200032, P.R. China
推荐引用方式(GB/T 7714)：
Liu Chen,Chen Rufu,Chen Yingtai,et al.Should a standard lymphadenectomy during pancreatoduodenectomy exclude para-aortic lymph nodes for all cases of resectable pancreatic head cancer? A consensus statement by the Chinese Study Group for Pancreatic Cancer (CSPAC)[J].INTERNATIONAL JOURNAL OF ONCOLOGY.2015,47(4):1512-1516.doi:10.3892/ijo.2015.3128.
APA：
Liu, Chen,Chen, Rufu,Chen, Yingtai,Fu, Deliang,Hong, Defei...&the Chinese Study Group for Pancreatic Cancer.(2015).Should a standard lymphadenectomy during pancreatoduodenectomy exclude para-aortic lymph nodes for all cases of resectable pancreatic head cancer? A consensus statement by the Chinese Study Group for Pancreatic Cancer (CSPAC).INTERNATIONAL JOURNAL OF ONCOLOGY,47,(4)
MLA：
Liu, Chen,et al."Should a standard lymphadenectomy during pancreatoduodenectomy exclude para-aortic lymph nodes for all cases of resectable pancreatic head cancer? A consensus statement by the Chinese Study Group for Pancreatic Cancer (CSPAC)".INTERNATIONAL JOURNAL OF ONCOLOGY 47..4(2015):1512-1516
